| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
12,090,000 |
| Market
Cap: |
2.37(M) |
| Last
Volume: |
4,012,246 |
Avg
Vol: |
4,001,203 |
| 52
Week Range: |
$0.1961 - $0.4503 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aethlon Medical is a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases. The Aethlon Hemopurifier® (Hemopurifier) is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. Co. is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johnson Sabrina Martucci |
Director |
– • – |
2019-12-31 |
4 |
D |
$0.84 |
$208 |
D/D |
(246) |
4,417 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2019-10-30 |
4 |
D |
$3.93 |
$452 |
D/D |
(115) |
2,608 |
|
- |
|
| Johnson Sabrina Martucci |
Director |
– • – |
2019-09-30 |
4 |
D |
$0.24 |
$866 |
D/D |
(3,684) |
69,944 |
|
- |
|
| Shah Chetan |
Director |
– • – |
2019-09-30 |
4 |
D |
$0.24 |
$866 |
D/D |
(3,684) |
359,075 |
|
- |
|
| Cipriani Guy F. |
Director |
– • – |
2019-09-30 |
4 |
D |
$0.24 |
$866 |
D/D |
(3,684) |
52,444 |
|
- |
|
| Fisher Charles J Jr |
Director |
– • – |
2019-09-30 |
4 |
D |
$0.24 |
$866 |
D/D |
(3,684) |
77,469 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2019-07-31 |
4 |
D |
$3.30 |
$373 |
D/D |
(113) |
2,723 |
|
- |
|
| Johnson Sabrina Martucci |
Director |
– • – |
2019-06-30 |
4 |
D |
$0.37 |
$1,363 |
D/D |
(3,684) |
73,628 |
|
- |
|
| Cipriani Guy F. |
Director |
– • – |
2019-06-30 |
4 |
D |
$0.37 |
$1,363 |
D/D |
(3,684) |
56,128 |
|
- |
|
| Shah Chetan |
Director |
– • – |
2019-06-30 |
4 |
D |
$0.37 |
$1,363 |
D/D |
(3,684) |
362,759 |
|
- |
|
| Fisher Charles J Jr |
Director |
– • – |
2019-06-30 |
4 |
D |
$0.37 |
$1,363 |
D/D |
(3,684) |
81,153 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2019-04-30 |
4 |
D |
$11.25 |
$1,451 |
D/D |
(129) |
2,836 |
|
- |
|
| Broenniman Edward G |
Director |
– • – |
2019-04-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
36,842 |
88,747 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2018-10-31 |
4 |
OE |
$1.04 |
$19,430 |
D/D |
18,683 |
212,370 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-10-31 |
4 |
OE |
$1.04 |
$1,593 |
D/D |
1,532 |
17,877 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2018-10-31 |
4 |
OE |
$1.04 |
$1,839 |
D/D |
1,768 |
20,358 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-09-28 |
4/A |
D |
$1.18 |
$4,738 |
D/D |
(4,015) |
56,686 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-07-31 |
4/A |
D |
$1.23 |
$2,076 |
D/D |
(1,688) |
60,701 |
|
- |
|
| Joyce James A |
Chairman, CEO, Secretary |
• • – |
2018-07-31 |
4 |
OE |
$1.23 |
$22,980 |
D/D |
18,683 |
193,687 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2018-07-31 |
4 |
OE |
$1.23 |
$2,210 |
D/D |
1,797 |
18,590 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-07-31 |
4 |
OE |
$1.23 |
$1,921 |
D/D |
1,562 |
16,345 |
|
- |
|
| Johnson Sabrina Martucci |
Director |
– • – |
2018-06-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
26,799 |
51,189 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-06-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
22,971 |
62,389 |
|
- |
|
| Frakes James B |
Chief Financial Officer |
• – – |
2018-04-30 |
4/A |
D |
$1.34 |
$2,575 |
D/D |
(1,922) |
39,418 |
|
- |
|
| Kenley Rodney S |
President |
• • – |
2018-04-30 |
4 |
OE |
$1.34 |
$2,139 |
D/D |
1,596 |
16,793 |
|
- |
|
181 Records found
|
|
Page 4 of 8 |
|
|
